BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2795690)

  • 1. Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody.
    Goldenberg A; Masui H; Divgi C; Kamrath H; Pentlow K; Mendelsohn J
    J Natl Cancer Inst; 1989 Nov; 81(21):1616-25. PubMed ID: 2795690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of epidermal growth factor (EGF) receptor density on human tumor xenografts using radiolabeled EGF and anti-(EGF receptor) mAb 425.
    Senekowitsch-Schmidtke R; Steiner K; Haunschild J; Möllenstädt S; Truckenbrodt R
    Cancer Immunol Immunother; 1996 Feb; 42(2):108-14. PubMed ID: 8620519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered biodistribution of indium-111-labeled monoclonal antibody 96.5 to tumors and normal tissues of nude mice bearing human melanoma xenografts in visceral organs.
    McCready DR; Price J; Balch CM; Murray JL
    Cancer Immunol Immunother; 1989; 30(5):257-61. PubMed ID: 2624918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific localization of In-111-labeled monoclonal antibody versus 67-Ga-labeled immunoglobulin in mice bearing human breast carcinoma xenografts.
    Haisma H; Goedemans W; de Jong M; Hilkens J; Hilgers J; Dullens H; Den Otter W
    Cancer Immunol Immunother; 1984; 17(1):62-5. PubMed ID: 6563945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrate-derivatized immunoconjugate of the anti-(carcinoembryonic antigen) monoclonal antibody C46: immunohistological reactivity and pharmacokinetic comparison with a randomly derivatized C46 immunoconjugate.
    Rosenstraus MJ; Davis WL; Lopes AD; D'Aleo CJ; Gilman SC
    Cancer Immunol Immunother; 1990; 32(4):207-13. PubMed ID: 2261596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a monoclonal antibody directed against the epidermal growth factor receptor binding site.
    Pellegrini R; Centis F; Martignone S; Mastroianni A; Tagliabue E; Tosi E; Ménard S; Colnaghi MI
    Cancer Immunol Immunother; 1991; 34(1):37-42. PubMed ID: 1760809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and biodistribution of a new anti-episialin monoclonal antibody 139H2 in ovarian-cancer-bearing nude mice.
    Molthoff CF; Pinedo HM; Schlüper HM; Boven E
    Cancer Immunol Immunother; 1991; 34(3):191-7. PubMed ID: 1756536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies.
    Koyama Y; Barrett T; Hama Y; Ravizzini G; Choyke PL; Kobayashi H
    Neoplasia; 2007 Dec; 9(12):1021-9. PubMed ID: 18084609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma.
    Wersäll P; Ohlsson I; Biberfeld P; Collins VP; von Krusenstjerna S; Larsson S; Mellstedt H; Boethius J
    Cancer Immunol Immunother; 1997 May; 44(3):157-64. PubMed ID: 9191875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma.
    Naramura M; Gillies SD; Mendelsohn J; Reisfeld RA; Mueller BM
    Cancer Immunol Immunother; 1993 Oct; 37(5):343-9. PubMed ID: 8402738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scintigraphic detection of xenografted tumors producing human basic fibroblast growth factor.
    Kobayashi H; Sakahara H; Hosono M; Shirato M; Konishi J; Takahashi JA; Oda Y; Kikuchi H; Endo K; Kozai Y
    Cancer Immunol Immunother; 1993 Oct; 37(5):281-5. PubMed ID: 8402731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of ansamitocin targeted to tumor by a bispecific monoclonal antibody.
    Okamoto K; Harada K; Ikeyama S; Iwasa S
    Jpn J Cancer Res; 1992 Jul; 83(7):761-8. PubMed ID: 1517150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody uptake in B-cell lymphomas: experimental studies in nude mouse xenografts.
    Schmid J; Möller P; Moldenhauer G; Dörken B; Bihl H; Matzku S
    Cancer Immunol Immunother; 1993; 36(4):274-80. PubMed ID: 7679951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-EphA2 antibodies decrease EphA2 protein levels in murine CT26 colorectal and human MDA-231 breast tumors but do not inhibit tumor growth.
    Kiewlich D; Zhang J; Gross C; Xia W; Larsen B; Cobb RR; Biroc S; Gu JM; Sato T; Light DR; Heitner T; Willuda J; Vogel D; Monteclaro F; Citkowicz A; Roffler SR; Zajchowski DA
    Neoplasia; 2006 Jan; 8(1):18-30. PubMed ID: 16533422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of drug-induced cytotoxicity by a bispecific monoclonal antibody that recognizes the epidermal growth factor receptor and doxorubicin.
    Morelli D; Sardini A; Villa E; Villa ML; Ménard S; Colnaghi MI; Balsari A
    Cancer Immunol Immunother; 1994 Mar; 38(3):171-7. PubMed ID: 8124685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody A7 coupled to magnetic particles as a contrast enhancing agent for magnetic resonance imaging of human colorectal carcinoma.
    Otsuji E; Kuriu Y; Okamoto K; Ichikawa D; Hagiwara A; Ito H; Nishimura T; Yamagishi H
    Cancer Immunol Immunother; 2006 Jun; 55(6):728-33. PubMed ID: 16273351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of 11C-labeled-4-N-(3-bromoanilino)-6,7-dimethoxyquinazoline as a positron emission tomography agent to monitor epidermal growth factor receptor expression.
    Wang H; Yu J; Yang G; Song X; Sun X; Zhao S; Mu D
    Cancer Sci; 2007 Sep; 98(9):1413-6. PubMed ID: 17627611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical comparison of three internalization assays applied to the evaluation of a given mAb as a toxin-carrier candidate.
    Casalini P; Caldera M; Canevari S; Ménard S; Mezzanzanica D; Tosi E; Gadina M; Colnaghi MI
    Cancer Immunol Immunother; 1993 Jul; 37(1):54-60. PubMed ID: 8099847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of
    Xu X; Liu T; Liu F; Guo X; Xia L; Xie Q; Li N; Huang H; Yang X; Xin Y; Zhu H; Yang Z
    Chin J Cancer Res; 2019 Apr; 31(2):400-409. PubMed ID: 31156310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and preclinical investigation of
    Shah SQ; Gul-E-Raana
    Mol Biol Rep; 2019 Apr; 46(2):1675-1682. PubMed ID: 30680596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.